1. Home
  2. THE CING
  3. Biomedical Sciences
  4. Neurogenetics Department
  5. Research
  6. Previous Grants

Neurogenetics Department

Previous Grants

  1. Molecular genetic study of Friedreich’s ataxia; Funding body: Muscular Dystrophy Association (USA); Co-investigator; Support period: 05/1992 – 04/1995; Total grant: US $ 178,200.00
  2. Neuromuscular diseases in eastern Mediterranean countries; Funding body: Muscular Dystrophy Association (USA); Co-investigator; Support period: 11/1994 – 10/1996; Total grant: US $ 204,400.00
  3. Molecular genetics of Charcot-Marie-Tooth type II; Funding body: Association Francaise contre les Myopathies (France); Co-investigator; Support period: 01/1995 – 12/1995; Total grant: FF 100,000.00
  4. Molecular genetics of Charcot-Marie-Tooth type II; Funding body: Association Francaise contre les Myopathies (France) ; Co-investigator; Support period: 01/1996 – 12/1996; Total grant: FF 180,000.00
  5. Mutation analysis in Greek and Cypriot Neurofibromatosis type I families; Funding body: Planning Bureau (Cyprus); Principal Investigator; Support period: 01/1996 – 12/1998; Total grant: CY £ 3,000.00
  6. Clinical and genetic studies of Charcot-Marie Tooth type II and recessive forms; Funding body: Muscular Dystrophy Association (USA); Co-investigator; Support period: 03/1996 – 06/1999; Total grant: US $ 201,150.00
  7. Neuromuscular diseases in eastern Mediterranean countries (continuation); Funding body: Muscular Dystrophy Association (USA); Co-investigator; Support period: 02/1997 – 06/1999; Total grant: US $ 158,000.00
  8. Investigating the role of molecular motors in ALS pathogenesis; Funding body: Muscular Dystrophy Association (USA); Co-investigator; Support period: 01/2000 – 12/2000; Total grant: US $ 65,000.00
  9. Genetic studies in autosomal recessive hereditary motor neuronopathy and autosomal recessive inclusion body myopathy; Funding body: Muscular Dystrophy Association (USA); Principal Investigator; Support period: 07/1999 – 06/2002; Total grant: US $ 180,000.00
  10. Neuromuscular diseases in eastern Mediterranean countries; Funding body: Muscular Dystrophy Association (USA); Co-investigator; Support period: 07/1999 – 06/2002; Total grant: US $ 135,000.00
  11. Identifying novel genomic regions and genes associated with inherited predisposition to breast and ovarian cancer; Funding body: Middle East Cancer Consortium (MECC); Co-principal Investigator; Support period: 07/2000 – 06/2002; Total grant: US $ 60,000.00
  12. Friedreich’s ataxia carrier screening in the population originating from the Paphos district of Cyprus; Funding body: United Nations Office for Project Services (UNOPS); Principal Investigator; Support period: 04/2001 – 11/2002; Total grant: CY £ 58,452.00
  13. Pancyprian epidemiological research for cancer; Funding body: Research Promotion Foundation (CYPRUS); Co-investigator; Support period: 07/2001 – 06/2003; Total grant: CY £ 45,000.00
  14. Genetic studies on hereditary nonpolyposis (HNPCC) colorectal cancer in families from Israel and Cyprus; Funding body: Middle East Cancer Consortium (MECC); Principal Investigator; Support period: 07/2001 – 06/2003; Total grant: US $ 60,000.00
  15. Identification of a novel Charcot-Marie-Tooth Type 2 (CMT2) gene; Funding body: Muscular Dystrophy Association (USA); Principal Investigator; Support period: 01/2002 – 12/2003; Total grant: US $ 185,850.00
  16. Pancyprian study of amyloid neuropathy; Funding body: Research Promotion Foundation (CYPRUS); Co-investigator; Support period: 12/2002 – 06/2005; Total grant: CY £ 49,700.00
  17. Neuromuscular diseases in Eastern Mediterranean countries; Funding body: Muscular Dystrophy Association (USA); Principal Investigator; Support period: 07/2002 – 06/2005; Total grant: US $ 192,180.00
  18. Quality in molecular genetic testing: development of certified reference materials; Funding body: European Commission, 5th Framework Programme; Co-investigator; Support period: 01/2002 – 12/2005; Total grant: EURO 99,843.00
  19. Exploratory investigation in the analysis of high dimensional SNP data; Funding body: GlaxoSmithKline Research & Development Ltd; Co-investigator; Support period: 12/2004 – 12/2005; Total grant: UK £ 64,893.00  
  20. Development of a high throughput microarray for the diagnosis of Charcot-Marie-Tooth neuropathy; Funding body: Research Promotion Foundation (CYPRUS) for participation in the EU 6th FP; Principal Investigator; Support period: 11/2006; Total grant: CY £ 5,000.00 
  21. Study of secondary genes in the pathogenesis of Mitochondrial encephalomyopathies; Funding body: Research Promotion Foundation (Cyprus); Co-investigator; Support period: 11/2005 – 11/2007; Total grant: CY £ 63,580.00
  22. Hosting an International meeting: 9th Congress of the Mediterranean Society of Myology; Funding body: Research Promotion Foundation (Cyprus); Principal Investigator; Support period: 02/2009 – 05/2009; Total grant: Euro 25,000.00
  23. Expression studies in hereditary motor neuronopathy type Jerash; Funding body: Telethon (Cyprus); Principal Investigator; Support period: 01/2007 – 06/2009; Total grant: CY £ 30,000.00
  24. Quantitative analysis of SMN genes based on the MLPA technique. A study of spinal muscular atrophy patients from Cyprus and Romania; Funding body: Research Promotion Foundation (Cyprus); Principal Investigator; Support period: 03/2008 – 02/2010; Total grant: Euro 20,082.00
  25. Atypical FSHMD from Cyprus and Slovenia; Funding body: Research Promotion Foundation (Cyprus); Co-investigator; Support period: 04/2008 – 03/2010; Total grant: CY £ 16,428.00
  26. Clinical and Genetic Investigation of SCA Cypriot patients; Funding body: Research Promotion Foundation (Cyprus); Co-investigator; Support period: 02/2009 – 02/2011; Total grant: Euro 120,054.00
  27. Identification of a novel axonal type Charcot-Marie-Tooth disease gene; Funding body: Association Française contre les Myopathies (France); Principal Investigator; Support period: 04/2009 – 03/2012; Total grant: Euro 30,000.00
  28. Investigation of Type 2 Diabetes susceptibility loci in the Cypriot population; Funding body: Research Promotion Foundation (Cyprus); Principal Investigator; Support period: 06/2011 – 08/2013; Total grant: Euro 180,000.00
  29. A study of modifier genes on disease severity in Multiple Sclerosis; Funding body: Research Promotion Foundation (Cyprus); Co-investigator; Support period: 10/2011 – 10/2013; Total grant: Euro 180,000.00
  30. A next-generation, secure linked data medical information space for semantically-interconnecting electronic health records and clinical trials system advancing patients safety in clinical research [Linked2Safety, Grant agreement number: 288328]; Funding body: FP7-ICT-2011 (EU); Co-investigator; Support period: 10/2011 – 09/2014; Total grant: Euro 4,410,000.00
  31. Functional Analysis of a novel MFN2 mutation found in Cyprus CMT2 patients; Funding body: Research Promotion Foundation (Cyprus); Principal Investigator; Support period: 03/2013 – 09/2015; Total grant: Euro 60,000.00
  32. Establishment of a translational facility at the Cyprus Institute of Neurology and Genetics; Funding body: Norwegian Financial Mechanism 2009-2014 (Norway); Co-principal Investigator; Support period: 03/2013 – 04/2016; Total grant: Euro 492,500.00
  33. The role of LRSAM1 in neuropathy; Funding body: Telethon Grants (Cyprus); Principal Investigator; Support period: 10/2013 – 09/2016; Total grant: Euro 60,000.00
  34. Integrated Precision Medicine Technologies Research Centre of Excellence – IPMT; Funding body: EU-H2020-WIDESPREAD-2014-3 GA: 763781; Co-investigator; Support period: 09/2017 – 08/2018; Total grant: Euro 399,997.50 
  35. Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases – PRECISESADS; Funding body: IMI [EU-EFPIA joint undertaking] GA: 115565; Co-investigator; Support period: 02/01/2014 – 01/31/2019; Total grant: 9,999,323.00  
Related Articles
Selected Publications

Minaidou A, Nicolaou P, Christodoulou K. Deregulation of LRSAM1 expression impairs the levels of TSG101, UBE2N, VPS28, MDM2 and EGFR. PLoS One. 2019 Feb 6;14(2):e0211814. doi: 10.1371/journal.pone. ...

Publications Archive

Original, peer reviewed articles Publications Archive Minaidou A, Nicolaou P, Christodoulou K. Deregulation of LRSAM1 expression impairs the levels of TSG101, UBE2N, VPS28, MDM2 and EGFR. ...

Current Grants

EU-H2020-WIDESPREAD-2014-2 GA: 669026 Christodoulou (PI) 07/01/2015 – 06/30/2020 Establishment of the Bioinformatics ERA Chair at the Cyprus Institute of Neurology and Genetics – ...

winner